You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Gastrointestinal/ Upper Foregut
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Image of the Month—Diagnosis

Arch Surg. 2003;138:914.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Answer: Zollinger-Ellison Syndrome

Figure 1. Hypertrophic folds within the body of the stomach, and a normal antrum.


 
Figure appears in full text version.
Figure 1.


Figure 2. Duodenum and proximal jejunum revealing multiple ulcers.


 
Figure appears in full text version.
Figure 2.


Gastrinomas are rare neuroendocrine tumors that secrete gastrin, producing severe peptic ulcer or even jejunal ulcer disease. Zollinger and Ellison1 were the first to attribute marked peptic ulcer disease in association with gastric acid hypersecretion and tumors of the pancreas. The discovery of gastrin in the 1960s helped further delineate the pathophysiology.2

Gastrinomas are the most common malignant pancreatic islet cell tumors. The incidence is rare, occurring in 0.1 to 3 million individuals per year.3 About 25% are associated with inherited familial disorders, such as multiple endocrine neoplasia type 1, and the remainder are sporadic. The incidence among patients with peptic ulcer disease is 0.1%; however, this approaches 1% in patients with recurrent disease.2 Sixty percent are malignant, of which 25% . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Image of the Month—Quiz Case
Eduards G. Ziedins and James C. Hebert
Arch Surg. 2003;138(8):913.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.